498 related articles for article (PubMed ID: 16813529)
21. Expression of mouse osteoclast K-Cl Co-transporter-1 and its role during bone resorption.
Kajiya H; Okamoto F; Li JP; Nakao A; Okabe K
J Bone Miner Res; 2006 Jul; 21(7):984-92. PubMed ID: 16813519
[TBL] [Abstract][Full Text] [Related]
22. Characterization of osteoclasts from patients harboring a G215R mutation in ClC-7 causing autosomal dominant osteopetrosis type II.
Henriksen K; Gram J; Schaller S; Dahl BH; Dziegiel MH; Bollerslev J; Karsdal MA
Am J Pathol; 2004 May; 164(5):1537-45. PubMed ID: 15111300
[TBL] [Abstract][Full Text] [Related]
23. Chloride channel 7 (ClCN7) gene mutations and autosomal dominant osteopetrosis, type II.
Waguespack SG; Koller DL; White KE; Fishburn T; Carn G; Buckwalter KA; Johnson M; Kocisko M; Evans WE; Foroud T; Econs MJ
J Bone Miner Res; 2003 Aug; 18(8):1513-8. PubMed ID: 12929941
[TBL] [Abstract][Full Text] [Related]
24. The PDE4 Inhibitors Roflumilast and Rolipram Rescue ADO2 Osteoclast Resorption Dysfunction.
Hong JM; Gerard-O'Riley RL; Acton D; Alam I; Econs MJ; Bruzzaniti A
Calcif Tissue Int; 2024 Apr; 114(4):430-443. PubMed ID: 38483547
[TBL] [Abstract][Full Text] [Related]
25. Osteoprotegerin ligand regulates osteoclast adherence to the bone surface in mouse calvaria.
O'Brien EA; Williams JH; Marshall MJ
Biochem Biophys Res Commun; 2000 Aug; 274(2):281-90. PubMed ID: 10913332
[TBL] [Abstract][Full Text] [Related]
26. Age of donor alters the effect of cyclic hydrostatic pressure on production by human macrophages and osteoblasts of sRANKL, OPG and RANK.
Evans CE; Mylchreest S; Andrew JG
BMC Musculoskelet Disord; 2006 Mar; 7():21. PubMed ID: 16519799
[TBL] [Abstract][Full Text] [Related]
27. Cloning and characterization of osteoclast precursors from the RAW264.7 cell line.
Cuetara BL; Crotti TN; O'Donoghue AJ; McHugh KP
In Vitro Cell Dev Biol Anim; 2006; 42(7):182-8. PubMed ID: 16948499
[TBL] [Abstract][Full Text] [Related]
28. Self-assembled RANK induces osteoclastogenesis ligand-independently.
Kanazawa K; Kudo A
J Bone Miner Res; 2005 Nov; 20(11):2053-60. PubMed ID: 16234979
[TBL] [Abstract][Full Text] [Related]
29. Degradation of the organic phase of bone by osteoclasts: a secondary role for lysosomal acidification.
Henriksen K; Sørensen MG; Nielsen RH; Gram J; Schaller S; Dziegiel MH; Everts V; Bollerslev J; Karsdal MA
J Bone Miner Res; 2006 Jan; 21(1):58-66. PubMed ID: 16355274
[TBL] [Abstract][Full Text] [Related]
30. ClC-7 expression levels critically regulate bone turnover, but not gastric acid secretion.
Supanchart C; Wartosch L; Schlack C; Kühnisch J; Felsenberg D; Fuhrmann JC; de Vernejoul MC; Jentsch TJ; Kornak U
Bone; 2014 Jan; 58():92-102. PubMed ID: 24103576
[TBL] [Abstract][Full Text] [Related]
31. Effects of vascular endothelial growth factor-C and -D on osteoclast differentiation and function in human peripheral blood mononuclear cells.
Motokawa M; Tsuka N; Kaku M; Kawata T; Fujita T; Ohtani J; Matsuda Y; Terao A; Tanne K
Arch Oral Biol; 2013 Jan; 58(1):35-41. PubMed ID: 22771550
[TBL] [Abstract][Full Text] [Related]
32. Quercetin suppresses bone resorption by inhibiting the differentiation and activation of osteoclasts.
Woo JT; Nakagawa H; Notoya M; Yonezawa T; Udagawa N; Lee IS; Ohnishi M; Hagiwara H; Nagai K
Biol Pharm Bull; 2004 Apr; 27(4):504-9. PubMed ID: 15056855
[TBL] [Abstract][Full Text] [Related]
33. Direct cell-cell contact between periodontal ligament fibroblasts and osteoclast precursors synergistically increases the expression of genes related to osteoclastogenesis.
Bloemen V; Schoenmaker T; de Vries TJ; Everts V
J Cell Physiol; 2010 Mar; 222(3):565-73. PubMed ID: 19927302
[TBL] [Abstract][Full Text] [Related]
34. A novel mutation (K378X) in the sequestosome 1 gene associated with increased NF-kappaB signaling and Paget's disease of bone with a severe phenotype.
Rea SL; Walsh JP; Ward L; Yip K; Ward BK; Kent GN; Steer JH; Xu J; Ratajczak T
J Bone Miner Res; 2006 Jul; 21(7):1136-45. PubMed ID: 16813535
[TBL] [Abstract][Full Text] [Related]
35. Induction of chemokines and chemokine receptors CCR2b and CCR4 in authentic human osteoclasts differentiated with RANKL and osteoclast like cells differentiated by MCP-1 and RANTES.
Kim MS; Magno CL; Day CJ; Morrison NA
J Cell Biochem; 2006 Feb; 97(3):512-8. PubMed ID: 16211583
[TBL] [Abstract][Full Text] [Related]
36. Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation.
Waguespack SG; Hui SL; Dimeglio LA; Econs MJ
J Clin Endocrinol Metab; 2007 Mar; 92(3):771-8. PubMed ID: 17164308
[TBL] [Abstract][Full Text] [Related]
37. Measurement of tartrate-resistant acid phosphatase and the brain isoenzyme of creatine kinase accurately diagnoses type II autosomal dominant osteopetrosis but does not identify gene carriers.
Waguespack SG; Hui SL; White KE; Buckwalter KA; Econs MJ
J Clin Endocrinol Metab; 2002 May; 87(5):2212-7. PubMed ID: 11994366
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of osteoclast mediated bone resorption--rationale for the design of new therapeutics.
Väänänen K
Adv Drug Deliv Rev; 2005 May; 57(7):959-71. PubMed ID: 15876398
[TBL] [Abstract][Full Text] [Related]
39. A bio-assay for effectors of osteoclast differentiation in serum from patients with bone disease.
Dugard MN; Sharp CA; Evans SF; Williams JH; Davie MW; Marshall MJ
Clin Chim Acta; 2005 Jun; 356(1-2):154-63. PubMed ID: 15936312
[TBL] [Abstract][Full Text] [Related]
40. Enhanced but hypofunctional osteoclastogenesis in an autosomal dominant osteopetrosis type II case carrying a c.1856C>T mutation in
Chen X; Zhang K; Hock J; Wang C; Yu X
Bone Res; 2016; 4():16035. PubMed ID: 27990310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
